SURPH@Duke | Summer Undergraduate Research in Pharmacology & Cancer Biology

The 2017 SURPH@Duke Faculty Mentors

Below is a list of the faculty participating in the SURPH@Duke Fellowship program for 2017. A brief description of each person’s research focus is provided along with a link for more information on their Duke faculty research page. Read through each of the faculty descriptions before choosing 3 to enter into the online application (1st, 2nd, and 3rd choice). Efforts will be made to place each accepted applicant in a lab of your first choice, however there is not a guarantee that everyone will receive a 1st choice placement. Please do not contact the faculty directly.

 

Mohammed Abou-Donia, PhD
Professor of Pharmacology and Cancer Biology
Professor of Neurobiology
Dr. Abou-Donia studies mechanisms of chemically-induced neurodegenerative disorders.
See: http://pharmacology.mc.duke.edu/faculty/abou-donia

James Alvarez, PhD
Assistant Professor of Pharmacology and Cancer Biology
Dr. Alvarez studies the cellular processes and molecular pathways that promote tumor dormancy, metastasis, and recurrence.
See: http://pharmacology.mc.duke.edu/faculty/alvarez.html

Gerard Blobe, MD, PhD
Professor of Medicine
Professor of Pharmacology & Cancer Biology
Dr. Blobe studies the role of transforming growth factor beta in cancer biology and vascular biology.
See:  http://www.cancer.duke.edu/faculty/blobe001/

Jen-Tsan Ashely Chi, MD, PhD
Associate Professor of Molecular Genetics and Microbiology
Associate Professor of Pharmacology and Cancer Biology
Dr. Chi studies how cancer cells adapt to the various tumor microenvironmental stresses and nutrient deprivations of solid tumors. These understandings will identify novel therapeutic approaches to target these tumor cells which often don't respond well to current therapeutics.
See: https://mgm.duke.edu/faculty-and-research/primary-faculty/jen-tsan-ashley-chi/

Christopher Counter, PhD
Professor of Pharmacology
Associate Professor of Radiation Oncology
Dr. Counter studies the molecular mechanisms underlying the process by which oncogenes promote tumor formation, and if inhibition of such proteins can reduce tumor formation.
See: http://pharmacology.mc.duke.edu/faculty/counter.html

Donald Fox, PhD
Assistant Professor of Pharmacology & Cancer Biology
Dr. Fox studies how organ repair occurs after injury using genetic, genomic and cell biological approaches. He also studies how chromosomal instability and error-prone division during development promotes cancer.
See: http://pharmacology.mc.duke.edu/faculty/fox.html

Sarah Goetz, PhD
Assistant Professor of Pharmacology & Cancer Biology
Dr. Goetz studies the role of primary cilia-mediated cell signaling in development and disease.
See: http://pharmacology.mc.duke.edu/faculty/goetz.html

Mark Herman, MD
Assistant Professor of Medicine
Assistant Professor of Pharmacology and Cancer Biology
Dr. Herman integrates genetic models with genomic and metabolomic approaches to study cellular nutrient sensing mechanisms and their contribution to cardiometabolic disease in model organisms and human populations.
See: https://medicine.duke.edu/faculty/mark-andrew-herman-md

Matthew Hirschey, PhD
Assistant Professor of Medicine
Assistant Professor of Pharmacology and Cancer Biology
Dr. Hirschey studies mitochondrial function and small metabolite regulation of nutrient metabolism by post-translational modifications. See:
http://stedman.mc.duke.edu/modules/stedman_team/index.php?id=16

Michael B. Kastan, MD, PhD
Professor of Pharmacology and Cancer Biology
Professor of Pediatrics
Executive Director, Duke Cancer Institute
Dr. Kastan studies molecular and cellular responses to DNA damage and other stresses.
See: http://pharmacology.mc.duke.edu/faculty/kastan.html

David Kirsch, MD, PhD
Associate Professor of Radiation Oncology
Assistant Professor of Pharmacology and Cancer Biology
Dr. Kirsch models cancer in the mouse and mechanisms of DNA damage response after radiation.
See: http://radonc.duke.edu/research-education/research-labs/radiation-and-cancer-biology/kirsch-lab

Cindy Kuhn, PhD
Professor of Pharmacology and Cancer Biology
Professor in Psychiatry and Behavioral Sciences
Dr. Kuhn studies gonadal steroids and monoamine function in the brain, and dopamine and addiction in development.
See: http://pharmacology.mc.duke.edu/faculty/kuhn.html

Ed Levin, PhD
Professor Psychiatry and Behavioral Science
Associate Professor, Department of Pharmacology
Dr. Levin studies basic neurobiology of learning and memory, neurobehavioral toxicology, and the development of novel therapeutic treatments for cognitive dysfunction.
See: http://fds.duke.edu/db/Nicholas/esp/faculty/edlevin

Corrine Linardic, MD, PhD
Associate Professor Pediatrics
Associate Professor of Pharmacology & Cancer Biology
Dr. Linardic studies the signaling pathways important in skeletal muscle cancer in children to identify new therapeutic targets for treatment.
See: http://pediatrics.duke.edu/faculty/details/0012491

Jason Locasale, PhD
Assistant Professor of Pharmacology & Cancer Biology
Dr. Locasale studies metabolism and its contribution to human cancer pathogenesis and treatment.
See: http://pharmacology.mc.duke.edu/faculty/locasale.html

Nancie J MacIver, MD, PhD
Assistant Professor of Pediatrics
Assistant Professor of Pharmacology and Cancer Biology
Dr. MacIver studies nutritional immunology and immunometabolism in the context of autoimmunity, diabetes, and infection.
See: https://pediatrics.duke.edu/faculty/nancie-jo-maciver-md-phd

Nimmi Ramanujam, MD
Professor of Biomedical Engineering
Professor of Pharmacology & Cancer Biology
Dr. Ramanujam develops imaging techniques to visualize hallmarks of cancer and uses these tools to leverage basic cancer discoveries that advance both diagnosis and therapy of cancer.
See: http://bme.duke.edu/faculty/nirmala-ramanujam

Vasantha Rao, PhD
Associate Professor of Ophthalmology
Associate Professor of Pharmacology and Cancer Biology
Dr. Rao studies the signaling pathways critical for eye lens development and function, and the development of cataracts using a combination of genetic and pharmacologic approaches. 
See:  http://dukeeyecenter.duke.edu/modules/eyectr_rsrch_basic/index.php?id=8

Kris Wood, PhD
Assistant Professor of Pharmacology and Cancer Biology
Assistant Professor of Medicine
Dr. Wood uses genomic and pharmacological strategies to define combination drug therapies for cancer.
See: http://pharmacology.mc.duke.edu/faculty/wood.html

 


© 2012 Pharmacology and Cancer Biology. Duke University School of Medicine. Site design: Academic Web Pages